BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//University of Manitoba//UMFOD Calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:6a39b20f68831@umanitoba.ca
SUMMARY:AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction Management - Internal Deadline
DESCRIPTION:AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction Management\n\nThis competitive program seeks proposals that improve safe, timely access to adequate antiviral COVID-19 treatment for eligible patients. Projects should leverage artificial intelligence (AI) and / or advanced clinical decision support to (1) identify patient eligibility based on current guidelines and clinical data and (2) proactively manage clinically significant drug–drug interactions (DDIs) to support appropriate disease management. \n\nIndividual projects requesting up to $500,000 USD will be considered. Maximum project length is 2 years. \n\n\nInternal Application Deadline: Jun 16, 2026 \n\nUMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4322\n\nProgram URL: https://cdn.pfizer.com/pfizercom/2026-05/2026%20IM%20G%20AI%20DDI%20COVID-19%20RES.pdf?VersionId=YYuNSOW.v8XvaTHyAu3Ik32CjpanpAC9\nInternal Deadline
X-ALT-DESC;FMTTYPE=text/html:AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility &\; Drug–Drug Interaction Management
This competitive program seeks proposals that improve safe\, timely access to adequate antiviral COVID-19 treatment for eligible patients. Projects should leverage artificial intelligence (AI) and / or advanced clinical decision support to (1) identify patient eligibility based on current guidelines and clinical data and (2) proactively manage clinically significant drug–drug interactions (DDIs) to support appropriate disease management.
Individual projects requesting up to $500\,000 USD will be considered. Maximum project length is 2 years.
Internal Application Deadline: Jun 16\, 2026
UMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4322
Program URL: https://cdn.pfizer.com/pfizercom/2026-05/2026%20IM%20G%20AI%20DDI%20COVID-19%20RES.pdf?VersionId=YYuNSOW.v8XvaTHyAu3Ik32CjpanpAC9
DTSTART:20260616T083000
DTEND:20260616T093000
BEGIN:VALARM
TRIGGER:-P2D
ACTION:DISPLAY
DESCRIPTION:Reminder for AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction Management
END:VALARM
END:VEVENT
END:VCALENDAR